跳至主要内容
临床试验/CTRI/2022/02/039995
CTRI/2022/02/039995尚未招募未知

Comparative clinical study to evaluate efficacy of Amritadi Guggulu and Vyoshadi Guggulu after Virechana in the management of Medoroga(Dyslipidemia)

All India Institute Of Ayurveda0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patient with Pratyatma Lakshan of Medoroga
  • Patient fulfilling the Diagnostic Criteria of Dyslipidemia
  • Patients of Age group between 21 to 50 years irrespective of gender, caste, creed and body weight
  • Patients fit for Virechana karma
  • Patient willing and able to give written consent in the study

排除标准

  • Patients with poorly controlled Diabetes Mellitus (HbA1c >10%) and Hypertension ( BP > 160 / 100 mm Hg)
  • Pregnant / lactating woman
  • Patients with genetic syndromes, severe cardiovascular disease or any other life threatening condition.
  • History of hypersensitivity to any of the trial drugs or their ingredients.
  • Patients unfit for Virechana karma
  • Patients having systemic illness which will interfere with the course of procedure.
  • Patients who are already enrolled in other study.

研究者

相似试验